Trial Profile
Efficacy of mTOR Inhibitors Everolimus and Sirolimus on the risk of cancer development in Chienese kidney tranplant recipients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Oct 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Sirolimus (Primary)
- Indications Cancer
- Focus Therapeutic Use
- 13 Oct 2016 New trial record